Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline or zonisamide add-on to levodopa in early Parkinson's disease
jRCTs051180098Completed
- Sponsor
- FP Pharmaceutical Corporation
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Parkinson's disease (PD) comparing Levodopa/DCI only, Levodopa/DCI + selegiline and Levodopa/DCI + zonisamide (3 arms). Primary endpoint: Percent change in DAT-SPECT SBR at 1 year. Started Jun 2016; status: completed.
02
Drugs
selegilinezonisamidelevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCTs051180098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180098.